JP5650718B2 - プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 - Google Patents

プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 Download PDF

Info

Publication number
JP5650718B2
JP5650718B2 JP2012505086A JP2012505086A JP5650718B2 JP 5650718 B2 JP5650718 B2 JP 5650718B2 JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012505086 A JP2012505086 A JP 2012505086A JP 5650718 B2 JP5650718 B2 JP 5650718B2
Authority
JP
Japan
Prior art keywords
antibiotics
disease
induced
pct
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012505086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523573A (ja
JP2012523573A5 (https=
Inventor
ベルクマン アンドレアス
ベルクマン アンドレアス
ストルック ヨアヒム
ストルック ヨアヒム
Original Assignee
ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40886944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5650718(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング, ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2012523573A publication Critical patent/JP2012523573A/ja
Publication of JP2012523573A5 publication Critical patent/JP2012523573A5/ja
Application granted granted Critical
Publication of JP5650718B2 publication Critical patent/JP5650718B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012505086A 2009-04-14 2010-04-14 プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 Active JP5650718B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09157886.4 2009-04-14
EP09157886 2009-04-14
PCT/EP2010/002279 WO2010118855A1 (en) 2009-04-14 2010-04-14 Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin

Publications (3)

Publication Number Publication Date
JP2012523573A JP2012523573A (ja) 2012-10-04
JP2012523573A5 JP2012523573A5 (https=) 2012-11-15
JP5650718B2 true JP5650718B2 (ja) 2015-01-07

Family

ID=40886944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012505086A Active JP5650718B2 (ja) 2009-04-14 2010-04-14 プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価

Country Status (15)

Country Link
US (3) US9046532B2 (https=)
EP (1) EP2419741B1 (https=)
JP (1) JP5650718B2 (https=)
CN (2) CN105334330A (https=)
CY (1) CY1122202T1 (https=)
DK (1) DK2419741T3 (https=)
ES (1) ES2751105T3 (https=)
HK (1) HK1221766A1 (https=)
HR (1) HRP20191862T1 (https=)
HU (1) HUE046182T2 (https=)
LT (1) LT2419741T (https=)
PL (1) PL2419741T3 (https=)
PT (1) PT2419741T (https=)
SI (1) SI2419741T1 (https=)
WO (1) WO2010118855A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2836841B1 (en) * 2012-04-12 2022-01-05 B.R.A.H.M.S GmbH Prognosis of adverse events in patients with suspected chronic heart failure
CN105528511A (zh) * 2014-10-25 2016-04-27 潘一琦 一种远程诊疗对比式问诊方法及其系统
CN107301319B (zh) * 2017-06-26 2021-02-26 济南市儿童医院 儿科临床及科研中抗菌药物使用危险评估系统
JP7444776B2 (ja) * 2017-12-20 2024-03-06 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス
EP3502706A1 (en) * 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
ATE395364T1 (de) * 1999-12-22 2008-05-15 Dade Behring Marburg Gmbh Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung
JP2005522669A (ja) * 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE102005034174A1 (de) * 2005-07-21 2007-02-08 B.R.A.H.M.S Ag Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen
FR2894675B1 (fr) * 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
CN103123359B (zh) * 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用

Also Published As

Publication number Publication date
HK1221766A1 (zh) 2017-06-09
WO2010118855A1 (en) 2010-10-21
HRP20191862T1 (hr) 2019-12-27
EP2419741A1 (en) 2012-02-22
HUE046182T2 (hu) 2020-02-28
CN102395888B (zh) 2017-05-03
PL2419741T3 (pl) 2020-01-31
JP2012523573A (ja) 2012-10-04
CY1122202T1 (el) 2020-11-25
LT2419741T (lt) 2019-11-11
EP2419741B1 (en) 2019-07-31
US9810699B2 (en) 2017-11-07
DK2419741T3 (da) 2019-11-04
US20180052179A1 (en) 2018-02-22
US20120100635A1 (en) 2012-04-26
US20150247871A1 (en) 2015-09-03
ES2751105T3 (es) 2020-03-30
US9046532B2 (en) 2015-06-02
SI2419741T1 (sl) 2019-12-31
PT2419741T (pt) 2019-11-04
CN105334330A (zh) 2016-02-17
CN102395888A (zh) 2012-03-28

Similar Documents

Publication Publication Date Title
CN102105794B (zh) 移植物衰竭和死亡的标志物
CN102257386B (zh) 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估
CN104303061B (zh) 患有疑似慢性心力衰竭的患者中不良事件的预后
US11835531B2 (en) Procalcitonin for the prognosis of adverse events
US20180052179A1 (en) Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
JP2012525571A (ja) 適切な治療を必要とする個体において心不全関連腎臓損傷を診断するための手段及び方法
EP2939028B1 (en) Use of scd14 or its fragments or derivatives for risk stratisfaction, diagnosis and prognosis
JP2023537224A (ja) Ｃｏｖｉｄ－１９患者の疾患重症度を予測するためのｇｄｆ－１５
JP2022534034A (ja) ＨＦｐＥＦのためのＩＧＦＢＰ７の比
HK1167181B (en) Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
HK1167181A (en) Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
HK1169165B (en) Procalcitonin for the prognosis of adverse events
HK1156104B (en) A marker for graft failure and mortality
HK1203611B (en) Prognosis of adverse events in patients with suspected chronic heart failure
HK1163813A1 (en) Use of adm in manufacturing an agent for evaluating heart failure and/or shortness of breath

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120913

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120913

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130219

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130520

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130527

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130813

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140514

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141014

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141113

R150 Certificate of patent or registration of utility model

Ref document number: 5650718

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250